Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| HS90B | P08238 | Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) (Heat shock protein family C member 3) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | Clinical-translation mediationImmune mediationMetabolism mediation | 3 | 0.50 | ||||
| ITB1 | P05556 | Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29) | Cancer-related genesCD markersFDA approved drug targets | 1 | Brain cancerLung cancerRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.50 | ||
| JAK3 | P52333 | Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) | Cancer-related genesDisease related genesEnzymes | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 3 | 0.50 | ||||
| KCC2B | Q13554 | Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) | Disease related genesEnzymesHuman disease related genes | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 3 | 0.50 | ||||
| KCNV1 | Q6PIU1 | Potassium voltage-gated channel subfamily V member 1 (Neuronal potassium channel alpha subunit HNKA) (Voltage-gated potassium channel subunit Kv8.1) | 6 | Fusion and delivery mediation | 3 | 0.50 | ||||
| MCLN1 | Q9GZU1 | Mucolipin-1 (ML1) (MG-2) (Mucolipidin) (Transient receptor potential channel mucolipin 1) (TRPML1) | Disease related genesHuman disease related genesPotential drug targets | 6 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 3 | 0.50 | |||
| MRP5 | O15440 | ATP-binding cassette sub-family C member 5 (EC 7.6.2.-) (EC 7.6.2.2) (Multi-specific organic anion transporter C) (MOAT-C) (Multidrug resistance-associated protein 5) (SMRP) (pABC11) | Cancer-related genesEnzymesMetabolic proteins | 13 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 3 | 0.50 | |||
| NCS1 | P62166 | Neuronal calcium sensor 1 (NCS-1) (Frequenin homolog) (Frequenin-like protein) (Frequenin-like ubiquitous protein) | Predicted intracellular proteins | Fusion and delivery mediation | 3 | 0.50 | ||||
| NKTR | P30414 | NK-tumor recognition protein (NK-TR protein) (Natural-killer cells cyclophilin-related protein) (Peptidyl-prolyl cis-trans isomerase NKTR) (PPIase) (EC 5.2.1.8) (Rotamase) | EnzymesMetabolic proteinsPredicted intracellular proteins | Other mediation | 3 | 0.50 | ||||
| NMDE2 | Q13224 | Glutamate receptor ionotropic, NMDA 2B (GluN2B) (Glutamate [NMDA] receptor subunit epsilon-2) (N-methyl D-aspartate receptor subtype 2B) (NMDAR2B) (NR2B) (N-methyl-D-aspartate receptor subunit 3) (NR3) (hNR3) | Disease related genesFDA approved drug targetsHuman disease related genes | 3 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 3 | 0.50 | |||
| OSBL6 | Q9BZF3 | Oxysterol-binding protein-related protein 6 (ORP-6) (OSBP-related protein 6) | Plasma proteinsPredicted intracellular proteins | Fusion and delivery mediationMetabolism mediation | 3 | 0.50 | ||||
| PCDG3 | Q9Y5H0 | Protocadherin gamma-A3 (PCDH-gamma-A3) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 3 | 0.50 | |||
| PCDG9 | Q9Y5G4 | Protocadherin gamma-A9 (PCDH-gamma-A9) | Predicted membrane proteins | 1 | Adhesion and uptake mediation | 3 | 0.50 | |||
| PDE4A | P27815 | 3',5'-cyclic-AMP phosphodiesterase 4A (EC 3.1.4.53) (DPDE2) (PDE46) (cAMP-specific phosphodiesterase 4A) | EnzymesFDA approved drug targetsMetabolic proteins | Acute upper respiratory infectionAllergic/hypersensitivity disorderAmyloidosis | Clinical-translation mediationReceptor-signaling mediation | 3 | 0.50 | |||
| PGAP3 | Q96FM1 | GPI-specific phospholipase A2-like PGAP3 (EC 3.1.1.-) (COS16 homolog) (hCOS16) (Gene coamplified with ERBB2 protein) (PER1-like domain-containing protein 1) (Post-GPI attachment to proteins factor 3) | Disease related genesHuman disease related genesPredicted intracellular proteins | 7 | Metabolism mediation | 3 | 0.50 | |||
| PGFRA | P16234 | Platelet-derived growth factor receptor alpha (PDGF-R-alpha) (PDGFR-alpha) (EC 2.7.10.1) (Alpha platelet-derived growth factor receptor) (Alpha-type platelet-derived growth factor receptor) (CD140 antigen-like family member A) (CD140a antigen) (Platelet-derived growth factor alpha receptor) (Platelet-derived growth factor receptor 2) (PDGFR-2) (CD antigen CD140a) | Cancer-related genesCD markersDisease related genes | 1 | Acute myeloid leukaemiaBCR-ABL1-negative chronic myeloid leukaemiaBrain cancer | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.50 | ||
| PP16A | Q96I34 | Protein phosphatase 1 regulatory subunit 16A (Myosin phosphatase-targeting subunit 3) | Predicted intracellular proteins | Metabolism mediation | 3 | 0.50 | ||||
| PPB1 | P05187 | Alkaline phosphatase, placental type (EC 3.1.3.1) (Alkaline phosphatase Regan isozyme) (Placental alkaline phosphatase 1) (PLAP-1) | Cancer-related genesEnzymesMetabolic proteins | 1 | Fusion and delivery mediation | 3 | 0.50 | |||
| PPBI | P09923 | Intestinal-type alkaline phosphatase (IAP) (Intestinal alkaline phosphatase) (EC 3.1.3.1) | EnzymesMetabolic proteinsPredicted intracellular proteins | Metabolism mediation | 3 | 0.50 | ||||
| PTPRM | P28827 | Receptor-type tyrosine-protein phosphatase mu (Protein-tyrosine phosphatase mu) (R-PTP-mu) (EC 3.1.3.48) | EnzymesPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 3 | 0.50 | |||
| RIGI | O95786 | Antiviral innate immune response receptor RIG-I (ATP-dependent RNA helicase DDX58) (EC 3.6.4.13) (DEAD box protein 58) (RIG-I-like receptor 1) (RLR-1) (RNA sensor RIG-I) (Retinoic acid-inducible gene 1 protein) (RIG-1) (Retinoic acid-inducible gene I protein) (RIG-I) | Disease related genesEnzymesHuman disease related genes | Clinical-translation mediationFusion and delivery mediationImmune mediation | 3 | 0.50 | ||||
| ROBO2 | Q9HCK4 | Roundabout homolog 2 | Disease related genesHuman disease related genesPlasma proteins | 1 | Adhesion and uptake mediation | 3 | 0.50 | |||
| ROBO3 | Q96MS0 | Roundabout homolog 3 (Roundabout-like protein 3) | 1 | Adhesion and uptake mediation | 3 | 0.50 | ||||
| RPSA2 | A0A8I5KQE6 | Small ribosomal subunit protein uS2B (37 kDa laminin receptor precursor) (37LRP) (37/67 kDa laminin receptor) (LRP/LR) (40S ribosomal protein SA) (40S ribosomal protein SA2) (67 kDa laminin receptor) (67LR) (Laminin receptor 1) (LamR) (Laminin-binding protein precursor p40) (LBP/p40) | Disease related genesEssential proteinsHuman disease related genes | Clinical-translation mediationMetabolism mediation | 3 | 0.50 | ||||
| S22AG | Q86VW1 | Solute carrier family 22 member 16 (Carnitine transporter 2) (CT2) (Fly-like putative transporter 2) (FLIPT2) (Flipt 2) (Organic cation transporter OKB1) (Organic cation/carnitine transporter 6) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediation | 3 | 0.50 |